Log in
Enquire now
Reprieve Cardiovascular

Reprieve Cardiovascular

Reprieve Cardiovascular is a heart Failure Device.

OverviewStructured DataIssuesContributors

Contents

reprievecardio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Location
United States
United States
CEO
Jim Dillon
Jim Dillon
Pitchbook URL
pitchbook.com/profiles...232828-39
Investors
Deerfield Management
Deerfield Management
‌
Cadence Capital
Abiomed
Abiomed
Rex Health Ventures
Rex Health Ventures
Sante Ventures
Sante Ventures
Genesis Capital
Genesis Capital
Arboretum Ventures
Arboretum Ventures
Lightstone Ventures
Lightstone Ventures
0
Total Funding Amount (USD)
68,000,000
Latest Funding Round Date
August 14, 2025
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
2
Country
United States
United States

Other attributes

Latest Funding Round Amount (USD)
61,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Reprieve Cardiovascular

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.